https://www.PR.com/ Latest news releases from PR.com for Procyrion Inc. Mon, 12 Oct 2026 05:44:41 -0400 © 2026 PR.com 60 en-us https://www.PR.com/images/logo_white.jpg https://www.PR.com/ 68 69 PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles. https://www.pr.com/press-release/643095 Sat, 24 Oct 2015 03:00:00 -0400 Houston medical device startup names Joseph Choi clinical development engineer. [PR.com] https://www.pr.com/press-release/643095 Procyrion Inc https://www.pr.com/press-release/640642 Thu, 08 Oct 2015 03:00:00 -0400 Houston heart pump developer Procyrion Inc. (http://www.procyrion.com) earned the 2015 Universal Biotech Innovation Prize for Aortix™, a catheter-based circulatory support device. With the top two most innovative projects, Procyrion and Pixium Vision, will share a grant award and a year of consulting services offered by organizer Universal Biotech, valued at €60,000. Procyrion CEO Benjamin A. Hertzog, Ph.D. and [PR.com] https://www.pr.com/press-release/640642 Procyrion Inc https://www.pr.com/press-release/639996 Fri, 02 Oct 2015 16:24:02 -0400 Diagnostic and therapeutic modalities presented at Transcatheter Cardiovascular Therapeutics annual scientific symposium. [PR.com] https://www.pr.com/press-release/639996 Procyrion Inc https://www.pr.com/press-release/639592 Thu, 01 Oct 2015 03:00:00 -0400 Out of 1,159 forward-thinking engineering innovations from 60 countries, micro heart pump developer Procyrion Inc. of Houston, Texas earned the $20,000 grand prize in the 2015 “Create the Future” Design Contest, organized by the publishers of NASA Tech Briefs and Medical Design Briefs magazines. With its catheter-deployed heart pump Aortix™, Procyrion aims to give NYHA Class III-IVa heart failure [PR.com] https://www.pr.com/press-release/639592 Procyrion Inc https://www.pr.com/press-release/637980 Sat, 19 Sep 2015 06:45:19 -0400 enmodes GmbH, a German company that designs and engineers innovative medical designs, put Houston-based Procyrion Inc.’s Aortix™ micro heart pump through a series of computational fluid dynamic simulations to improve the overall design and performance of the prototype in preparation for first-in-human trials. The simulation and bench top flow loop results will be presented at the at the 23rd Annual Congress of [PR.com] https://www.pr.com/press-release/637980 Procyrion Inc https://www.pr.com/press-release/626456 Wed, 01 Jul 2015 03:00:00 -0400 Thinner than a #2 pencil and with a sleek appearance more like a torpedo than a life-saving heart pump, Aortix™ has been selected, from a pool of more than 280 applicants, as one of 17 life science projects named a semi finalist in the Universal Biotech Innovation Prize 2015. Two winners, who will share prize earnings of €60,000 plus consulting services, will be announced October 5, 2015 in Paris, France. [PR.com] https://www.pr.com/press-release/626456 Procyrion Inc https://www.pr.com/press-release/618080 Wed, 06 May 2015 03:00:00 -0400 Procyrion, Inc., developers of the first catheter-deployed circulatory assist device for the ambulatory treatment of heart failure, appointed bioengineer interns Omar Benavides, Ph.D. to senior product development engineer and Tanner Songkakul to product development engineer. Benavides and Songkakul will facilitate the building and testing of the hardware and software control systems necessary to deploy, power and operate [PR.com] https://www.pr.com/press-release/618080 Procyrion Inc https://www.pr.com/press-release/614150 Fri, 10 Apr 2015 03:00:00 -0400 Is a long-term power lead exiting the femoral artery feasible in powering an intravascular blood pump? [PR.com] https://www.pr.com/press-release/614150 Procyrion Inc https://www.pr.com/press-release/610104 Sat, 14 Mar 2015 03:00:00 -0400 Research shows reduced workload of the heart, decreased oxygen demand. [PR.com] https://www.pr.com/press-release/610104 Procyrion Inc https://www.pr.com/press-release/606111 Wed, 18 Feb 2015 03:00:00 -0500 Medical device firm Procyrion, Inc., developing the first catheter-deployed circulatory assist device for the ambulatory treatment of heart failure, announced today that interventional cardiologist Dr. Manesh Patel of Duke University Medical Center has joined the company’s scientific advisory board. Dr. Patel serves as Director of Interventional Cardiology and Cardiac Catheterization Labs across the Duke University [PR.com] https://www.pr.com/press-release/606111 Procyrion Inc